Few & Far Between: How Biotech Gets Built
Total duration:
26 h 32 min
Video Episode 68: Sinan Gölhan, CEO at GelTech Labs
Few & Far Between: How Biotech Gets Built
44:16
Video Episode 67: Aoife Brennan, President and CEO of Climb Bio
Few & Far Between: How Biotech Gets Built
71:59
Episode 66: Mark Abelson, Founder of Ora Clinical
Few & Far Between: How Biotech Gets Built
43:27
Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience
Few & Far Between: How Biotech Gets Built
66:51
Video Episode 64 - Professor Justin Stebbing
Few & Far Between: How Biotech Gets Built
47:30
Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences
Few & Far Between: How Biotech Gets Built
61:16
Episode 62: Ken Suzuki, Chief Marketing Officer at Nautilus Biotechnology
Few & Far Between: How Biotech Gets Built
44:15
Episode 61: Woody Bryan, President and CEO of Revolo Biotherapeutics
Few & Far Between: How Biotech Gets Built
45:18
Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech
Few & Far Between: How Biotech Gets Built
42:11
Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech
Few & Far Between: How Biotech Gets Built
43:41
Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences
Few & Far Between: How Biotech Gets Built
44:43
Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation
Few & Far Between: How Biotech Gets Built
44:53
Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
Few & Far Between: How Biotech Gets Built
39:28
Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®
Few & Far Between: How Biotech Gets Built
38:46
Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
Few & Far Between: How Biotech Gets Built
45:11
Episode 53: Frank David, Founder and Managing Director, Pharmagellan
Few & Far Between: How Biotech Gets Built
50:46
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI
Few & Far Between: How Biotech Gets Built
52:05
Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio
Few & Far Between: How Biotech Gets Built
55:05
Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova
Few & Far Between: How Biotech Gets Built
52:02
Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health
Few & Far Between: How Biotech Gets Built
35:37
Episode 48: John Celebi, President and CEO, Sensei Bio
Few & Far Between: How Biotech Gets Built
38:46
Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures
Few & Far Between: How Biotech Gets Built
43:29
Episode 47 - Marc Lajoie, CEO at Outpace Bio
Few & Far Between: How Biotech Gets Built
48:25
Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris
Few & Far Between: How Biotech Gets Built
37:26
Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics
Few & Far Between: How Biotech Gets Built
44:29
Episode 43: Isaac Stoner, Co-founder and CEO at Octagon Therapeutics
Few & Far Between: How Biotech Gets Built
39:18
Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical
Few & Far Between: How Biotech Gets Built
36:14
Episode 41: Craig Serra, Head of Clinical Research Scientific and Technical Engagement, Flatiron Health
Few & Far Between: How Biotech Gets Built
35:24
Episode 40: Professor Justin Stebbing, Editor-in-Chief, Oncogene journal
Few & Far Between: How Biotech Gets Built
33:23
Episode 39: Dr. Keith Flaherty, Director of Clinical Research at Massachusetts General Hospital Cancer Center
Few & Far Between: How Biotech Gets Built
45:10
Episode 38: Dr. Ole Isacson, Professor of Neurology and Neuroscience, Harvard Medical School
Few & Far Between: How Biotech Gets Built
38:27
Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche
Few & Far Between: How Biotech Gets Built
41:31
Episode 36: Zak Kohane, Department of Biomedical Informatics at Harvard Medical School
Few & Far Between: How Biotech Gets Built
51:43
Episode 35: Charlene Son Rigby, CEO at Global Genes
Few & Far Between: How Biotech Gets Built
44:55
Episode 34: Dan Mandell, CEO at GRO Biosciences
Few & Far Between: How Biotech Gets Built
44:45
